Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition, with a median survival of

Saved in:
Bibliographic Details
Published in:European respiratory review 2012-06, Vol.21 (124), p.152-160
Main Authors: Günther, Andreas, Korfei, Martina, Mahavadi, Poornima, von der Beck, Daniel, Ruppert, Clemens, Markart, Philipp
Format: Article
Language:English
Subjects:
Alveolar epithelial type II cells
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Disease Progression
endoplasmic reticulum stress
Enzyme Inhibitors - therapeutic use
Epithelial Cells - physiology
fibroblast
Humans
idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis - drug therapy
Idiopathic Pulmonary Fibrosis - physiopathology
Indoles - therapeutic use
pathophysiology
Pulmonary Alveoli - physiopathology
Pyridones - therapeutic use
Review: IPF
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition, with a median survival of
ISSN:0905-9180
1600-0617
DOI:10.1183/09059180.00001012